Literature DB >> 35838073

Demographics and medical comorbidities among hospitalized patients with Prader-Willi Syndrome: A National Inpatient Sample analysis.

James Luccarelli1,2,3.   

Abstract

Prader-Willi Syndrome (PWS) is a multi-system genetic disorder characterized by hyperphagia and a range of medical complications. While register and cohort studies have explored the natural course of the syndrome, there is little nationally-representative data. In this study the National Inpatient Sample, a de-identified all-payors database of acute care hospital discharges in the United States, was queried for patients discharged with a diagnosis of PWS in 2019. Hospitalizations involving PWS were compared to hospitalizations without a PWS diagnosis matched based on demographic and hospital factors. In total, 540 hospitalizations (95% CI: 513-567) included a diagnosis of PWS. Median age at time of admission was 22 years, with an interquartile range of 6.3-37.8 years. Respiratory conditions accounted for 110 (20.4%) of primary discharge diagnoses, with infectious conditions for 70 (13.0%) and digestive conditions for 65 (12.0%). Hospitalizations involving PWS were significantly more likely to involve respiratory failure (OR 5.49; 95% CI 3.86-7.80), septicemia (OR 2.80, 95% CI 1.97-3.96), or intestinal obstruction and ileus (OR 6.29; 95% CI 3.70-10.7) compared to matched hospitalizations without PWS. Obesity was diagnosed in 230 PWS hospitalizations (42.6%; OR 3.86, 95% CI 3.17-4.72 relative to non-PWS hospitalizations). These results point to an ongoing need for the improved diagnosis and treatment of PWS complications, and highlight the importance of specific billing codes for rare diseases to enhance the collection of real world evidence.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  Prader-Willi Syndrome; cohort studies; demography

Mesh:

Year:  2022        PMID: 35838073      PMCID: PMC9474715          DOI: 10.1002/ajmg.a.62901

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.578


  28 in total

Review 1.  Prader-Willi syndrome and early-onset morbid obesity NIH rare disease consortium: A review of natural history study.

Authors:  Merlin G Butler; Virginia Kimonis; Elisabeth Dykens; June A Gold; Jennifer Miller; Roy Tamura; Daniel J Driscoll
Journal:  Am J Med Genet A       Date:  2017-12-22       Impact factor: 2.802

Review 2.  Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction.

Authors:  Maithé Tauber; Charlotte Hoybye
Journal:  Lancet Diabetes Endocrinol       Date:  2021-02-26       Impact factor: 32.069

Review 3.  Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.

Authors:  Jasmanda Wu; Cunlin Wang; Sengwee Toh; Federica Edith Pisa; Larry Bauer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-01-30       Impact factor: 2.890

4.  Cross-cultural comparisons of obesity and growth in Prader-Willi syndrome.

Authors:  O Dudley; B McManus; A Vogels; J Whittington; F Muscatelli
Journal:  J Intellect Disabil Res       Date:  2008-02-20

5.  Prader-Willi syndrome.

Authors:  Suzanne B Cassidy; Daniel J Driscoll
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

6.  Prader Willi syndrome and obstructive sleep apnea: co-occurrence in the pediatric population.

Authors:  Karim Sedky; David S Bennett; Andres Pumariega
Journal:  J Clin Sleep Med       Date:  2014-04-15       Impact factor: 4.062

7.  The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood.

Authors:  Jill V Butler; Joyce E Whittington; Anthony J Holland; Catherine J McAllister; Anthony P Goldstone
Journal:  Dev Med Child Neurol       Date:  2009-12-23       Impact factor: 5.449

Review 8.  Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth.

Authors:  Hans-Georg Eichler; Francesco Pignatti; Brigitte Schwarzer-Daum; Ana Hidalgo-Simon; Irmgard Eichler; Peter Arlett; Anthony Humphreys; Spiros Vamvakas; Nikolai Brun; Guido Rasi
Journal:  Clin Pharmacol Ther       Date:  2020-11-12       Impact factor: 6.875

9.  Causes of death in Prader-Willi syndrome: Prader-Willi Syndrome Association (USA) 40-year mortality survey.

Authors:  Merlin G Butler; Ann M Manzardo; Janalee Heinemann; Carolyn Loker; James Loker
Journal:  Genet Med       Date:  2016-11-17       Impact factor: 8.822

Review 10.  Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician.

Authors:  Lawrence Blonde; Kamlesh Khunti; Stewart B Harris; Casey Meizinger; Neil S Skolnik
Journal:  Adv Ther       Date:  2018-10-24       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.